Primary tabs

Search
Limit to
Export 80 results:
Filters: Author is Wim Van Molle
2022
Round table Q&A on Vaccine Lifecycle management, Van Molle, Wim , PDA Biomanufacturing Conference "Biopharmaceutical Solutions to Prepare for Healthcare Challenges",, 20/09/2022, Amsterdam, The Netherlands, (2022)
Sustainability in Quality Control of Vaccines: Applying the 3R’s principle and implementing the 4th R. , Van Molle, Wim , PDA Biomanufacturing Conference "Biopharmaceutical Solutions to Prepare for Healthcare Challenges", 21/09/2022, Amsterdam, The Netherlands, (2022)
White paper recommendations summary, Van Molle, Wim , Inno4Vac ST2 (Chimichurri) Stakeholders meeting, 4/10/2022, Florence, Italy, (2022)
WP20 Regulatory. Workshop outcome, dissemination, gaps, and next steps: from models to showcases, Van Molle, Wim , Inno4Vac 1st Annual Meeting 2022, 6/10/2022, Siena, Italy, (2022)
2021
Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain., Bekeredjian-Ding, Isabelle, Trouvin Jean-Hugues, Depraetere Hilde, La Carine, Suvarnapunya Akamol E., Bell Alan, Mann Alex, Meij Pauline, Bethony Jeffrey M., Schellhaas Linda, et al. , Biologicals, 2021 Nov, Volume 74, (2021)
Evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases: regulatory considerations, Tesolin, L., Van Molle Wim, and Brusselmans Koen , (2021)
The Role of EDQM and OMCLs, Van Molle, Wim , Responsable des affaires réglementaires, 13/01/2021, Issue Culture in vivo ASBL, (2021)
Round table discussion, Van Molle, Wim , Human Infection Studies Considerations on manufacturing of challenge agents- viruses (SARS-CoV-2/COVID-19) and parasites as examples A Joint Wellcome Trust/HIC-Vac, hVIVO and IABS webina, 31/01/2021, (2021)
2018
The Role of EDQM and OMCLs, Van Molle, Wim , Responsable des affaires réglementaires , 18/12/2018, Issue Culture in vivo ASBL, (2018)
The Role of EDQM and OMCLs, Van Molle, Wim , Responsable des affaires réglementaires, 15/01/2018, Issue Culture in vivo ASBL, (2018)
2017
Appoaching EMA and National regulatory authorties: who, when and how., Van Molle, Wim , 2017 Vaccines Bioprocess Development & Commercialization Workshop, 2017, Issue MIT Center for Biomedical Innovation (CBI), Cambrige, MA, USA, (2017)
Evaluation of quality and non-clinical data for licencing of vaccines, Van Molle, Wim , WHO GLO Evaluation of quality and non-clinical data for licensing of vaccines, 2017, Issue WHO, Athens, Greece, (2017)
Method transfer of the hexavalent vaccine Vaxelis: a bumpy road with a happy ending, Van Molle, Wim , OMCL Annual Meeting, 2017, Issue EDQM, Budapest, Hungary, (2017)
Panel discussion on CMC for vaccines: "Responding in Time: Dealing with Predictable and Unpredictable", Van Molle, Wim , 2017 Vaccines Bioprocess Development & Commercialization Workshop, 2017, Issue MIT Center for Biomedical Innovation (CBI), Cambrdige, MA, USA, (2017)

QR code

QR code for this page URL